Marc Beer Has Shown A Consistent Ability Over His Professional Life To Make Big Things Happen:

In 1987, Marc Beer completed his Bachelor’s Degree in Business at Miami University. From there, he launched into a career that has spanned three decades and has been filled with consistent success in various medical industry-oriented businesses such as biotechnology and the pharmaceutical sector. The first big work experience that Marc Beer found upon graduating from college was with pharmaceutical company Genzyme. It was in this job posting that he was able to show the value of the education that he had obtained as well as his natural skills as a businessman. Marc Beer took full advantage of this opportunity and quickly rose through the ranks until he was promoted to Genzyme’s Global Marketing Vice President.

Once he ascended to his VP position with Genzyme, Marc Beer made great use of the opportunity. His tenure in this role saw the company attain a higher profile in its industry than it had ever enjoyed before. The promotional work that Marc did with the Genzyme product line was instrumental in ensuring that countless medical patients were able to access medical treatment that they were in great need of. After becoming so successful in this endeavor, Marc Beer decided that he wanted to continue to help people and this led him to found a company known as ViaCell in 2000. 

ViaCell was Marc Beer’s opportunity to really make his own mark in the world of business. The company did some innovative work in the area of stem cell collection that was harvested from umbilical cord blood. Marc Beer and his ViaCell team looked into many treatment uses that these stem cells could be applied to. The growth of the company was rapid and impressive and five years after launching ViaCell, Marc Beer was able to land the company on the publically traded list. In 2007, he sold the firm for $300 million to the Perkin Elmer company.

After he completed his ViaCell sale, Marc Beer suffered a tragedy in his family and decided to step away from professional life for a while and regroup. He enjoyed this time with his children and found it to be a rejuvenating experience but he also had the desire to return to the world of business. It was at the urging of his daughter that he would reemerge on the scene with a new company and a new mission to help medical patients. This new venture that Marc Beer is involved with now is called Renovia. The company is working toward finding solutions for pelvic floor disorders. This is a condition that affects countless women and the stigma behind it has been one that has caused a great deal of damage. Marc and his team are working to break that stigma and find better treatments for this condition that so many women suffer from.  Learn more: https://medium.com/@marc.beer

Things have been going great for Marc Beer and his team that he has assembled at Renovia. The firm gained the approval of its debut product form the FDA and he was also able to raise a substantial amount of funding through a Series B round. It is clear that Marc Beer is once again out there and making a difference.

Follow Marc Beer on Facebook

Marc Beer On His Business Career

There are many people who have changed their careers multiple times but Marc Beer has always known he wanted to be a businessman and has no intention of changing that anytime soon. He currently serves as the co-founder, chairman and CEO of Renovia, a company dedicated to developing medical products so they can mass produce them and deliver them to the patients who desperately need them. Despite it being a fairly new company, they have already endured much success with a grant to the tune of $42 million. They also have had their first product receive a seal of approval from the FDA. They’ve funded their research and development with $32 million and their financial department with an additional $10 million. Of course, this isn’t his first company.


Back in May of 2000, he became the founder and CEO of his very first business known as Viacell. Based out of Cambridge, the company is dedicated to trying to discover as many vaccines and cures as they can find. They perform this procedure by extracting the stem cells from the umbilical
cords
of mothers who recently gave birth and analyzing their genetic makeup. During this, they attempt to find a biomarker so they can see if there are any cures in those cells. The company did pretty well considering its short tenure as they went public five years later and employed close to
half a thousand employees at one point. However, he soon sold it off for a significant profit.


Once the sale was complete, he was hoping to continue his career but, before he could do that, his wife tragically passed away of a pulmonary embolism. After the funeral, he decided to help out with the children but it wasn’t long before his daughter made him realize the business industry needs his unique blend of talent and ingenuity. As such, he co-founded Renovia in August of 2016 and it is currently based out of the Boston area. Over the years, he has provided advice to the next generation of aspiring entrepreneurs, telling them to learn from the mistakes of their past, focus on giving back to the people who need it most and always keep a level head when dealing with various setbacks and obstacles. Learn more: https://blogwebpedia.com/marc-beer-entrepreneurial-spirit-biotech.html


One of the diseases they are currently attempting to treat is known as pelvic floor disorder. They’ve found that it affects nearly a quarter of the female population nationwide which is why they’re doing everything in their power to try and help the women who are currently suffering from this condition. In the future of his career, he hopes to be able to help as many people as he can so we wish him luck.

Connect with Marc Beer on Facebook

How Marc Beer Bounced Back

As the chairman, co-founder and CEO of Renovia, Marc Beer is no stranger to adversity in his career but many people are wondering how the 58-year-old businessman and entrepreneur has managed to stay on top all these years. He recently agreed to chat with Stephen Callahan about how he got to where he is today and where he hopes to go in the future of his career. He first started college in the autumn of 1983 where he realized he wanted to major in business. After graduating with a business degree in the spring of 1987, he then received his first job offer from a company called Abbott working in their sales department as one of their developers. He held this role for about six years before he moved on to Biostar where he worked in their marketing department.


After two years with the company, he accepted a position as the vice president of global marketing at a business known as Genzyme. He worked for the company for about four years before making the conscious decision to start his own business. Headquartered in Cambridge, Viacell was first
established in May of 2000 to analyze the blood stem cells of umbilical cords
in order to try and uncover various vaccines and cures for a wide variety of diseases. He decided to go public with the company in 2005 and they had close to 500 employees but, not long afterward, they decided to close up shop and sell the company for a massive $300 million to Perkin Elmer.


Upon completion of the sale, he was all set to move on to his next big entrepreneurial venture but, before he could, there was a tragic death in the family as his wife passed away of a pulmonary embolism at the age of 42. After the funeral, he was forced to step up as the primary parent,
driving them to and from soccer practice,
packing their lunches and helping them with schoolwork as per necessary. Two years later, however, his daughter made him realize the business world needed him and he resolved to open a new company called Renovia. Established in 2016, the
company is the brainchild of Dr. Ray Iglesias, Yolanda Lorie, and Beer and is dedicated to developing and producing medical products to help patients who are suffering from various conditions.

Learn more: https://blogwebpedia.com/marc-beer-entrepreneurial-spirit-biotech.html


This new venture has already been successful as the FDA just approved their first product for public use and they were awarded a $32 million grant continue researching and developing new products. In fact, some of the conditions they are currently attempting to treat affect nearly a
a quarter of the female population nationwide and this includes types of pelvic floor disorders.

Connect with Marc Beer on Facebook

Marc Beer Focused on Improving the Lives of Women Suffering from Pelvic Floor Disorders

Marc Beer is a legendary serial entrepreneur who has a proven track record of starting numerous successful startups. Beer latest venture in the world of startups is Renovia Inc a Boston based medical technology company that he serves at the helm as co-founder, CEO, and Chairman. The idea of starting Renovia was from Dr. Ray Iglesias a long time gynecologist with over 35 years worth of experience. Ray Iglesias had spent most of his career time performing pelvic floor surgeries to women and experienced firsthand the kind of pain women went through during the surgical procedure. He then decided to find an alternative method that could help women get treatment without going for surgery. Iglesias spent nearly a decade to come up with the method, and it is after discovering the method that he called Beer and sold him the idea. Together with Yolanda Lorie, the three in 2016 launched the company and Beer being an experienced serial entrepreneur was appointed to head the company and help in marketing as well as look for capital.

Renovia Inc in less than three years has become a leading provider of affordable alternative healthcare for pelvic floor disorders. Pelvic floor disorder is a condition that affects the pelvic muscles rendering it difficult to control bowel movement. The condition includes pelvic organ prolapsed, fecal incontinence, and the most common is urinary incontinence. The condition in the US alone has affected close to25 percent of women, thus needs to be taken seriously. The industry, according to Beer, is a multimillion-dollar industry with ambulatory physicians cost between 2005 and 2006 standing at 298 million dollars.

Renovia Inc under Marc Beer leadership has been able to secure both series A and Series B financing. The most recent Series B funding saw the firm receive capital injection worth 32 million dollars and an additional 10 million dollars venture funding. The funding would not have been a success was it not the involvement of three healthcare investment firms. The firms were the New York-based Perceptive Advisors, Longwood Fund who also participated in Series A funding and the Missouri based Ascension Ventures. Beer while making a statement concerning the Series B funding was excited and full of praise for the three companies and said that the partnership would go a long way in helping to diagnose better, treat and improve the lives of millions of women suffering from the condition. Learn more: https://www.crunchbase.com/person/marc-beer

Renovia in 2018 had its first line of products approved by the FDA and is focusing on eliminating the stigma associated with pelvic floor disorders. Many women, just because of the stigma, do not seek treatment for the condition, and this is one of the things Renovia is focused on reversing. Pelvic floor disorder has many causes, and the most common causes are uterine fibroids, endometriosis, chronic pelvic inflammation, and interstitial cystitis, among others.

Follow Marc Beer on Facebook

Marc Beer: The Chairman of Biotechnology Leading Us to the Future of Medicine

Marc Beer is an American businessman who recently became Chairman of the Board for LumeNXT. According to Prnewswire.com, LumeNXT is a privately-held company that develops a surgical illumination product line designed for minimally invasive surgeries. Marc Beer has more than 25 years of experience in the commercialization and development of biotechnology, devices, diagnostics, and pharmaceuticals. Marc stated in a recent interview that he is proud to work with the engineers and surgeons associated with LumeNXT. He also believes the company will have more of an impact when minimal invasive surgeries are more common. Learn more: https://patch.com/massachusetts/boston/renovias-marc-beer-raises-42m-treat-womens-health-issues

The Co-Founder of LumeNXT Paul Rhyne praises Marc’s ability to lead multiple companies successfully. Rhyne also believes that Marc’s experience is a strong asset to his organization. In 2016 Marc Beer raised $42 million dollars as the Founding Chairman of the Board for Renovia, Inc. Renovia, Inc is a company that delivers digital therapeutic and diagnostic devices for women with pelvic floor disorder. Before his term at Renovia, Inc. Marc Beer was a Founding Chairman at Minerva Neurosciences Inc. Minerva is a clinical biopharmaceutical company that develops and test medicines for Parkinson’s Disease, mood disorders, insomnia, major depressive disorders, and schizophrenia.

Marc Beer has also served on the Biotechnology Industry Organization (BIO) Emerging Companies Section Governing Board and a member of the Mass Life Science Board of the Commonwealth of Massachusetts. He was the Vice President of Global Marketing at Genzyme and Founding Chairman of the board of Good Start Genetics, Inc. Marc was once a CEO of ViaCell and on the Board of Directors of Erytech Pharma. He also worked in marketing and sales at Abbott Laboratories. Marc is also a member of the Graduate Studies and Research Advisory Council of Notre Dame University and a B.S. from Miami University (Oxford, OH).

Today, Marc Beer has yet another opportunity to successfully lead a business in the growing biotechnology field. He has a track record of successful ventures into businesses that are on the cutting edge of science and technology. His peers acknowledge the skills and expertise he has acquired within the industry. In an earlier 2018 interview, Marc stated that his key to success was the ability to hire and organize the best people in their field. He also noted that to generate the best product possible, you have to continuously scrutinize the product. Marc Beer is truly a visionary that puts his best efforts and talents to work productively. His accomplishments leave us all wondering what’s next for this entrepreneur?

Renovia Gets A Major Boost After Marc Beer Closes $42 Million

Renovia Inc, set to move forward with several pelvic floor disorder products after its founding CEO sourced $42 million in Series B round and venture debt. He managed to raise $32 million in Series B and $10 million in venture debt. Renovia Inc., is a pharmaceutical startup that is focused on finding treatment for pelvic floor disorders in women.

Renovia is developing diagnostic and therapeutic products that will put pelvic floor cases to rest. According to a research, over 250 million women across the world have urinary incontinence, one type of pelvic floor disorders. One of the first products Renovia developed, Leva, was approved in April by FDA.

The Series B round of financing was conducted by Perceptive Advisors and Ascension Ventures which are based in New York and Missouri respectively. The funds will be used to develop four more therapeutic and diagnostic products including a modern generation of the Leva device.

Marc Beer expressed his excitement for the support he garnered from leading investors in the healthcare sector. In a statement, he stated that the supportive investors share the same vision with his company to improve the lives of women suffering from pelvic floor disorders around the world. He looks to avail valuable data to their customers that will inform new treatment options, drive greater knowledge and ultimately, improve understanding of the disorders. In the long-run, long-term healthcare costs will be reduced.

Marc Beer has led a successful career in the healthcare industry working in prominent companies and establishing companies. He served at OvaScience as a strategic consultant. OvaScience had shown interests of merging with Millendo Therapeutics. Learn more: https://gazetteday.com/2018/10/marc-beer-funding-renovia/

A Look at the Career Life of Marc Beer

Marc Beer is the co-founder and CEO of the Boston-based medtech company. He brings over 25 years of development and commercialization experience in the pharmaceutical, biotechnology, diagnostic and device industries. He earned his BS degree from Miami University, OHIO. He has worked at several companies and founded a couple of companies that thrived in the industry.

As the Founding CEO of ViaCell, he led the biotechnology company from inception to when it had over 300 employees and went public. The company was later acquired by PerkinElmer in 2007. At the same time, Beer was a member of Erytech Pharma’s Board of Directors. Mr. Beer was the Founding Chairman of the board of directors as well as chairman of the compensation committee of Good Start Genetics. He serves in various capacities at Minerva Neurosciences. He sits in the Miami University Business Advisory Council as a member. Formerly, he sat in the Notre Dame Research and Commercialization Advisory Committee as well as Norte Dame Graduate Studies Research and Advisory Council as a member. The work background of Marc Beer is extensive. His dedicated service in the industry has promoted the industry significantly.